vs
Side-by-side financial comparison of Dexcom (DXCM) and HANOVER INSURANCE GROUP, INC. (THG). Click either name above to swap in a different company.
HANOVER INSURANCE GROUP, INC. is the larger business by last-quarter revenue ($1.7B vs $1.3B, roughly 1.3× Dexcom). Dexcom runs the higher net margin — 21.2% vs 11.9%, a 9.3% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 5.5%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 3.8%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
The Hanover Insurance Group, Inc. is an insurance company based in Worcester, Massachusetts. It was the original name of a property-liability insurance firm established in 1852, and it remained a publicly traded company under that name until the early 1990s, when it changed its name to Allmerica Property & Casualty Companies.
DXCM vs THG — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.7B |
| Net Profit | $267.3M | $198.5M |
| Gross Margin | 62.9% | — |
| Operating Margin | 25.6% | 17.3% |
| Net Margin | 21.2% | 11.9% |
| Revenue YoY | 21.6% | 5.5% |
| Net Profit YoY | 153.6% | 18.2% |
| EPS (diluted) | $0.67 | $5.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.7B | ||
| Q3 25 | $1.2B | $1.7B | ||
| Q2 25 | $1.2B | $1.7B | ||
| Q1 25 | $1.0B | $1.6B | ||
| Q4 24 | $1.1B | $1.6B | ||
| Q3 24 | $994.2M | $1.6B | ||
| Q2 24 | $1.0B | $1.5B |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $198.5M | ||
| Q3 25 | $283.8M | $178.7M | ||
| Q2 25 | $179.8M | $157.1M | ||
| Q1 25 | $105.4M | $128.2M | ||
| Q4 24 | $151.7M | $167.9M | ||
| Q3 24 | $134.6M | $102.1M | ||
| Q2 24 | $143.5M | $40.5M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 17.3% | ||
| Q3 25 | 20.1% | 14.9% | ||
| Q2 25 | 18.4% | 12.7% | ||
| Q1 25 | 12.9% | 11.6% | ||
| Q4 24 | 17.0% | 16.1% | ||
| Q3 24 | 15.3% | 9.6% | ||
| Q2 24 | 15.7% | 6.2% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 11.9% | ||
| Q3 25 | 23.5% | 10.7% | ||
| Q2 25 | 15.5% | 9.5% | ||
| Q1 25 | 10.2% | 8.0% | ||
| Q4 24 | 13.6% | 10.6% | ||
| Q3 24 | 13.5% | 6.5% | ||
| Q2 24 | 14.3% | 2.6% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $5.46 | ||
| Q3 25 | $0.70 | $4.90 | ||
| Q2 25 | $0.45 | $4.30 | ||
| Q1 25 | $0.27 | $3.50 | ||
| Q4 24 | $0.37 | $4.60 | ||
| Q3 24 | $0.34 | $2.80 | ||
| Q2 24 | $0.35 | $1.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $1.1B |
| Total DebtLower is stronger | — | $843.3M |
| Stockholders' EquityBook value | $2.7B | $3.6B |
| Total Assets | $6.3B | $16.9B |
| Debt / EquityLower = less leverage | — | 0.24× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $1.1B | ||
| Q3 25 | $1.8B | $915.7M | ||
| Q2 25 | $1.2B | $244.1M | ||
| Q1 25 | $904.9M | $315.1M | ||
| Q4 24 | $606.1M | $435.5M | ||
| Q3 24 | $621.2M | $427.1M | ||
| Q2 24 | $939.2M | $337.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | $843.3M | ||
| Q3 25 | — | $843.0M | ||
| Q2 25 | — | $347.8M | ||
| Q1 25 | — | $722.5M | ||
| Q4 24 | — | $722.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $3.6B | ||
| Q3 25 | $2.7B | $3.4B | ||
| Q2 25 | $2.6B | $3.2B | ||
| Q1 25 | $2.3B | $3.0B | ||
| Q4 24 | $2.1B | $2.8B | ||
| Q3 24 | $2.0B | $2.9B | ||
| Q2 24 | $2.4B | $2.6B |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $16.9B | ||
| Q3 25 | $7.5B | $16.8B | ||
| Q2 25 | $7.3B | $15.7B | ||
| Q1 25 | $6.8B | $15.5B | ||
| Q4 24 | $6.5B | $15.3B | ||
| Q3 24 | $6.4B | $15.4B | ||
| Q2 24 | $6.8B | $14.9B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.24× | ||
| Q3 25 | — | 0.25× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.24× | ||
| Q4 24 | — | 0.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $378.2M |
| Free Cash FlowOCF − Capex | — | $377.0M |
| FCF MarginFCF / Revenue | — | 22.6% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.91× |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.2B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $378.2M | ||
| Q3 25 | $659.9M | $554.4M | ||
| Q2 25 | $303.0M | $206.6M | ||
| Q1 25 | $183.8M | $38.9M | ||
| Q4 24 | $301.4M | $213.5M | ||
| Q3 24 | $199.5M | $394.7M | ||
| Q2 24 | $279.4M | $139.5M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $377.0M | ||
| Q3 25 | $579.4M | $551.4M | ||
| Q2 25 | $208.9M | $204.9M | ||
| Q1 25 | $96.8M | $37.1M | ||
| Q4 24 | $176.8M | $210.5M | ||
| Q3 24 | $88.3M | $392.3M | ||
| Q2 24 | $213.3M | $137.3M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 22.6% | ||
| Q3 25 | 47.9% | 33.1% | ||
| Q2 25 | 18.1% | 12.4% | ||
| Q1 25 | 9.3% | 2.3% | ||
| Q4 24 | 15.9% | 13.3% | ||
| Q3 24 | 8.9% | 25.1% | ||
| Q2 24 | 21.2% | 8.9% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 0.1% | ||
| Q3 25 | 6.7% | 0.2% | ||
| Q2 25 | 8.1% | 0.1% | ||
| Q1 25 | 8.4% | 0.1% | ||
| Q4 24 | 11.2% | 0.2% | ||
| Q3 24 | 11.2% | 0.2% | ||
| Q2 24 | 6.6% | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 1.91× | ||
| Q3 25 | 2.33× | 3.10× | ||
| Q2 25 | 1.69× | 1.32× | ||
| Q1 25 | 1.74× | 0.30× | ||
| Q4 24 | 1.99× | 1.27× | ||
| Q3 24 | 1.48× | 3.87× | ||
| Q2 24 | 1.95× | 3.44× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
THG
| Personal Lines Segment | $684.6M | 41% |
| Core Commercial Lines Segment | $617.8M | 37% |
| Specialty Lines Segment | $377.9M | 23% |
